REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 79 filers reported holding REPLIMUNE GROUP INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $17,284,000 | -47.3% | 449,879 | -58.2% | 9.32% | -22.8% |
| Q1 2021 | $32,798,000 | -30.4% | 1,075,000 | -13.0% | 12.08% | +7.7% |
| Q4 2020 | $47,115,000 | +299.3% | 1,235,000 | +141.0% | 11.22% | +87.4% |
| Q3 2020 | $11,798,000 | -2.1% | 512,500 | +5.7% | 5.98% | -23.4% |
| Q2 2020 | $12,052,000 | – | 485,000 | – | 7.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,050,187 | $53,866,302 | 35.13% |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $37,055,978 | 5.02% |
| Redmile Group, LLC | 3,811,988 | $67,319,708 | 2.92% |
| Nan Fung Group Holdings Ltd | 189,339 | $3,343,727 | 2.28% |
| Altium Capital Management LP | 148,000 | $2,613,680 | 1.45% |
| Integral Health Asset Management, LLC | 395,000 | $6,975,700 | 1.40% |
| BVF INC/IL | 2,143,036 | $37,846,016 | 1.38% |
| Resolute Capital Asset Partners LLC | 82,500 | $1,457 | 1.06% |
| SECTORAL ASSET MANAGEMENT INC | 262,200 | $4,630,452 | 0.89% |
| Frazier Life Sciences Management, L.P. | 686,762 | $12,128,217 | 0.88% |